You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 20, 2024

Details for Patent: 9,796,712


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,796,712 protect, and when does it expire?

Patent 9,796,712 protects EXKIVITY and is included in one NDA.

This patent has sixty-one patent family members in thirty-nine countries.

Summary for Patent: 9,796,712
Title:Heteroaryl compounds for kinase inhibition
Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.
Inventor(s): Huang; Wei-Sheng (Acton, MA), Gong; Yongjin (Belmont, MA), Li; Feng (Winchester, MA), Bencivenga; Nicholas E. (Malden, MA), Dalgarno; David C. (Brookline, MA), Kohlmann; Anna (Winchester, MA), Shakespeare; William C. (Southborough, MA), Thomas; Ranny M. (Sharon, MA), Zhu; Xiaotian (Newton, MA), West; Angela V. (Franklin, MA), Youngsaye; Willmen (Boston, MA), Zhang; Yun (Acton, MA), Zhou; Tianjun (Belmont, MA)
Assignee: ARIAD Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:15/600,023
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 9,796,712

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Takeda Pharms Usa EXKIVITY mobocertinib succinate CAPSULE;ORAL 215310-001 Sep 15, 2021 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,796,712

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015277786 ⤷  Try a Trial
Australia 2019206024 ⤷  Try a Trial
Brazil 112016029662 ⤷  Try a Trial
Canada 2949793 ⤷  Try a Trial
Chile 2016003222 ⤷  Try a Trial
Chile 2017003103 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.